News
Despite failing to achieve MRD-negativity after induction, patients with Ph+ acute lymphoblastic leukemia treated with ...
You may hear this called Philadelphia positive leukaemia. Dasatinib is a type cancer growth blocker called a tyrosine kinase inhibitor. It works by blocking a signal that tells leukaemia cells to grow ...
Real world evidence on treatment efficacy and safety of tyrosine kinase inhibitors in patients with chronic myeloid leukemia.
Dasatinib (Sprycel) is another TKI that targets the BCR-ABL protein. This drug is a pill taken once a day with or without food. Dasatinib can be used as the first treatment for CML, but it can also be ...
Predictors of septic shock among BCR/ABL-positive chronic myeloid leukemia patients admitted for sepsis: A nationwide study and analysis. This is an ASCO Meeting Abstract from the 2025 ASCO Annual ...
Researchers discovered that COVID-19 and chronic hepatitis B share key genetic pathways related to the immune system. This ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results